Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Immunefi (IMU) vs Ripple (XRP) Price & Performance

ImmunefiTrade
RippleTrade

Price performance (Past 24H)

Key statistics

Immunefi vs Ripple — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Ripple trades at Rp19,888 (market cap Rp1.246,89T, Rp20,72T 24h volume). The key difference: Ripple is far larger — about 46129855.7× Immunefi's market cap, and Immunefi's circulating supply is 873,4M / 10B IMU (9%) versus 62,5B / 100B XRP (63%) for Ripple. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Ripple for 68 Days on average.

IMUXRP
Market Cap
Rp27,03MRp1.246,89T
Volume (24h)
Rp39,91MRp20,72T
Circulating Supply
873,4M / 10B IMU (9%)62,5B / 100B XRP (63%)
Typical Hold Time
5 Days68 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Immunefi

Immunefi (IMU) currently trades with a market cap of Rp27.03M and a circulating supply of 873.4 million tokens (9% of max supply). The asset shows limited market activity with a short average hold time of 5 days, indicating potential speculative trading patterns. Recent coverage appears to confuse the token with a corporate entity, requiring careful verification of crypto-specific metrics.

Outlook remains cautious due to low circulation rate and potential identity confusion. Key opportunity lies in proper crypto ecosystem positioning, while major risks include liquidity constraints and market misidentification. Investors should verify on-chain metrics and exchange listings before considering exposure.

Ripple

XRP is trading at Rp20,104 with a market cap of Rp1.254 trillion, showing neutral technical signals amid a 43% decline since early 2026. The token faces bearish moving averages but neutral oscillators, with key support at Rp19,259 and resistance at Rp20,395. Recent ecosystem developments include Deutsche Bank and Société Générale adopting Ripple's infrastructure, while six XRP ETFs now hold approximately $1 billion in combined assets despite recent price pressure.

Overall outlook remains cautious with potential for recovery based on institutional adoption and ETF inflows, but major risks include prolonged bearish trends, regulatory uncertainty, and high volatility. Investors should monitor key support levels and on-chain signals for reversal indications.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IMU

No sentiment data available yet.

XRP
50% Buy50% Sell
Avg holding period · 68 Days

Top news

Latest headlines on both assets

About Immunefi

Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.

Read more on IMU

About Ripple

A crypto asset was created by Ripple to be a speedy, less costly and more scalable alternative to both other digital assets and existing monetary payment platforms like SWIFT. It is the native digital asset on the XRP Ledger—an open-source, permissionless and decentralized blockchain technology that can settle transactions in 3-5 seconds.

Read more on XRP